SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-20-041091
Filing Date
2020-12-04
Accepted
2020-12-04 16:53:53
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea130871-s3_biomxinc.htm S-3 507298
2 OPEN MARKET SALE AGREEMENTSM, DATED DECEMBER 4, 2020, BY AND BETWEEN BIOMX INC. ea130871ex1-2_biomxinc.htm EX-1.2 246619
3 FORM OF INDENTURE ea130871ex4-5_biomxinc.htm EX-4.5 385864
4 OPINION OF SULLIVAN & WORCESTER LLP ea130871ex5-1_biomxinc.htm EX-5.1 19617
5 CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO., A FIRM IN THE DELOITTE GLOBAL NETWORK ea130871ex23-1_biomxinc.htm EX-23.1 3131
6 GRAPHIC img_001.jpg GRAPHIC 12763
7 GRAPHIC ex5-1_001.jpg GRAPHIC 17543
8 GRAPHIC ex5-1_002.jpg GRAPHIC 5947
  Complete submission text file 0001213900-20-041091.txt   1213950
Mailing Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004 646-465-9000
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251151 | Film No.: 201370448
SIC: 2836 Biological Products, (No Diagnostic Substances)